REFERENCES
- Ames B. N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res 1975; 31: 347–364, [INFOTRIEVE], [CSA]
- Arinc E., Philpot M. Preparation and properties of partially purified pulmonary cytochrome P-450 from rabbits. J. Biol. Chem 1976; 251: 3213–3220, [INFOTRIEVE], [CSA]
- Ashkar S., Mesentsev A., Zhang W. X., Mastyugin V., Dunn M. W., Laniado-Schwartzman M. Retinoic acid induces corneal epithelial CYP4B1 gene expression and stimulates the synthesis of inflammatory 12-hydroxyeicosanoids. J. Ocul. Pharmacol. Ther 2004; 20: 65–74, [INFOTRIEVE], [CSA], [CROSSREF]
- Baer B. R., Rettie A. E., Henne K. R. Bioactivation of 4-ipomeanol by CYP4B1: adduct characterization and evidence for an enedial intermediate. Chem. Res. Toxicol 2005; 18: 855–864, [INFOTRIEVE], [CSA], [CROSSREF]
- Bains S. K., Gardiner S. M., Mannweiler K., Gillett D., Gibson G. G. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid. Biochem. Pharmacol 1985; 34: 3221–3229, [INFOTRIEVE], [CSA], [CROSSREF]
- Becker G. M., Breeze R. G., Carlson J. R. Autoradiographic evidence of 3-methylindole covalent binding to pulmonary epithelial cells in the goat. Toxicology 1984; 31: 109–121, [INFOTRIEVE], [CSA], [CROSSREF]
- Beland F., Kadlubar F. Metabolic acitvation and DNA adducts of aromatic amines and nitroaromatic hydrocarbons. Chemical Carcinogenesis and Mutagenesis I, C. Couper, P. Grover. Springer, New York 1990; 267–325
- Bellec G., Dreano Y., Bail J. P., Menez J. F., Berthou F. Cytochrome P450 hydroxylation of carbon atoms of the alkyl chain of symmetrical N-nitrosodialkylamines by human liver microsomes. Mutat. Res 1997; 377: 199–209, [INFOTRIEVE], [CSA]
- Bonazzi A., Mastyugin V., Mieyal P. A., Dunn M. W., Laniado-Schwartzman M. Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium. J. Biol. Chem 2000; 275: 2837–2844, [INFOTRIEVE], [CSA], [CROSSREF]
- Boyd M. R. Evidence for the Clara cell as a site of cytochrome P450-dependent mixed-function oxidase activity in lung. Nature 1977; 269: 713–715, [INFOTRIEVE], [CSA], [CROSSREF]
- Boyd M. R. Biochemical mechanisms in chemical-induced lung injury: roles of metabolic activation. Crit. Rev. Toxicol 1980; 7: 103–176, [INFOTRIEVE], [CSA]
- Boyd M. R., Burka L. T., Harris T. M., Wilson B. J. Lung-toxic furanoterpenoids produced by sweet potatoes (Ipomoea batatas) following microbial infection. Biochim. Biophys. Acta 1974; 337: 184–195, [INFOTRIEVE], [CSA]
- Bylund J., Finnstrom N., Oliw E. H. Gene expression of a novel cytochrome P450 of the CYP4F subfamily in human seminal vesicles. Biochem. Biophys. Res. Commun 1999; 261: 169–174, [INFOTRIEVE], [CSA], [CROSSREF]
- Carr B. A., Ramakanth S., Dannan G. A., Yost G. S. Characterization of pulmonary CYP4B2, specific catalyst of methyl oxidation of 3-methylindole. Mol. Pharmacol 2003; 63: 1137–1147, [INFOTRIEVE], [CSA], [CROSSREF]
- Chen L. J., Hecht S. S., Peterson L. A. Characterization of amino acid and glutathione adducts of cis-2-butene-1,4-dial, a reactive metabolite of furan. Chem. Res. Toxicol 1997; 10: 866–874, [INFOTRIEVE], [CSA], [CROSSREF]
- Choudhary D., Jansson I., Stoilov I., Sarfarazi M., Schenkman J. B. Expression patterns of mouse and human CYP orthologs (families 1–4) during development and in different adult tissues. Arch. Biochem. Biophys 2005; 436: 50–61, [INFOTRIEVE], [CSA], [CROSSREF]
- Christmas P., Jones J. P., Patten C. J., Rock D. A., Zheng Y., Cheng S. M., et al. Alternative splicing determines the function of CYP4F3 by switching substrate specificity. J. Biol. Chem 2001; 276: 38166–38172, [INFOTRIEVE], [CSA]
- Czerwinski M., McLemore T. L., Gelboin H. V., Gonzalez F. J. Quantification of CYP2B7, CYP4B1, and CYPOR messenger RNAs in normal human lung and lung tumors. Cancer Res 1994; 54: 1085–1091, [INFOTRIEVE], [CSA]
- Czerwinski M., McLemore T. L., Philpot R. M., Nhamburo P. T., Korzekwa K., Gelboin H. V., et al. Metabolic activation of 4-ipomeanol by complementary DNA-expressed human cytochromes P-450: evidence for species-specific metabolism. Cancer Res 1991; 51: 4636–4638, [INFOTRIEVE], [CSA]
- DePillis G. D., Ozaki S., Kuo J. M., Maltby D. A., Ortiz de Montellano P. R. Autocatalytic processing of heme by lactoperoxidase produces the native protein-bound prosthetic group. J. Biol. Chem 1997; 272: 8857–8860, [INFOTRIEVE], [CSA], [CROSSREF]
- Devereux T. R., Serabjit-Singh C. J., Slaughter S. R., Wolf C. R., Philpot R. M., Fouts J. R. Identification of cytochrome P-450 isozymes in nonciliated bronchiolar epithelial (Clara) and alveolar type II cells isolated from rabbit lung. Exp. Lung. Res 1981; 2: 221–230, [INFOTRIEVE], [CSA]
- Domin B. A., Philpot R. M. The effect of substrate on the expression of activity catalyzed by cytochrome P-450: metabolism mediated by rabbit isozyme 6 in pulmonary microsomal and reconstituted monooxygenase systems. Arch. Biochem. Biophys 1986; 246: 128–142, [INFOTRIEVE], [CSA], [CROSSREF]
- Du L., Neis M. M., Ladd P. A., Lanza D. L., Yost G. S., Keeney D. S. Effects of the differentiated keratinocyte phenotype on expression levels of CYP1–4 family genes in human skin cells. Toxicol. Appl. Pharmacol 2005; 215: 135–144, [CSA]
- Dutcher J. S., Boyd M. R. Species and strain differences in target organ alkylation and toxicity by 4-ipomeanol. Predictive value of covalent binding in studies of target organ toxicities by reactive metabolites. Biochem. Pharmacol 1979; 28: 3367–3372, [INFOTRIEVE], [CSA], [CROSSREF]
- Fenna R., Zeng J., Davey C. Structure of the green heme in myeloperoxidase. Arch. Biochem. Biophys 1995; 316: 653–656, [INFOTRIEVE], [CSA], [CROSSREF]
- Finnstrom N., Bjelfman C., Soderstrom T. G., Smith G., Egevad L., Norlen B. J., et al. Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. Eur. J. Clin. Invest 2001; 31: 880–886, [INFOTRIEVE], [CSA], [CROSSREF]
- Fisher M. B., Zheng Y. M., Rettie A. E. Positional specificity of rabbit CYP4B1 for omega-hydroxylation1 of short-medium chain fatty acids and hydrocarbons. Biochem. Biophys. Res. Commun 1998; 248: 352–355, [INFOTRIEVE], [CSA], [CROSSREF]
- Franklin M. R., Wolf C. R., Serabjit-Singh C., Philpot R. M. Quantitation of two forms of pulmonary cytochrome P-450 in microsomes, using substrate specificities. Mol. Pharmacol 1980; 17: 415–420, [INFOTRIEVE], [CSA]
- Furukawa M., Nishimura M., Ogino D., Chiba R., Ikai I., Ueda N., et al. Cytochrome p450 gene expression levels in peripheral blood mononuclear cells in comparison with the liver. Cancer Sci 2004; 95: 520–529, [INFOTRIEVE], [CSA], [CROSSREF]
- Gasser R., Philpot R. M. Primary structures of cytochrome P-450 isozyme 5 from rabbit and rat and regulation of species-dependent expression and induction in lung and liver: identification of cytochrome P-450 gene subfamily IVB. Mol. Pharmacol 1989; 35: 617–625, [INFOTRIEVE], [CSA]
- Gotoh O. Substrate recognition sites in cytochrome P450 family 2 (CYP2) proteins inferred from comparative analyses of amino acid and coding nucleotide sequences. J. Biol. Chem 1992; 267: 83–90, [INFOTRIEVE], [CSA]
- Guan X., Fisher M. B., Lang D. H., Zheng Y. M., Koop D. R., Rettie A. E. Cytochrome P450-dependent desaturation of lauric acid: isoform selectivity and mechanism of formation of 11-dodecenoic acid. Chem. Biol. Interact 1998; 110: 103–121, [INFOTRIEVE], [CSA], [CROSSREF]
- Guengerich F. P. Preparation and properties of highly purified cytochrome p-450 and NADPH-cytochrome P-450 reductase from pulmonary microsomes of untreated rabbits. Mol. Pharmacol 1977; 13: 911–923, [INFOTRIEVE], [CSA]
- Hashizume T., Imaoka S., Hiroi T., Terauchi Y., Fujii T., Miyazaki H., et al. cDNA cloning and expression of a novel cytochrome p450 (cyp4f12) from human small intestine. Biochem. Biophys. Res. Commun 2001; 280: 1135–1141, [INFOTRIEVE], [CSA], [CROSSREF]
- Henne K. R., Fisher M. B., Iyer K. R., Lang D. H., Trager W. F., Rettie A. E. Active site characteristics of CYP4B1 probed with aromatic ligands. Biochemistry 2001a; 40: 8597–8605, [INFOTRIEVE], [CSA], [CROSSREF]
- Henne K. R., Kunze K. L., Zheng Y. M., Christmas P., Soberman R. J., Rettie A. E. Covalent linkage of prosthetic heme to CYP4 family P450 enzymes. Biochemistry 2001b; 40: 12925–12931, [INFOTRIEVE], [CSA], [CROSSREF]
- Hiratsuka M., Nozawa H., Konno Y., Saito T., Konno S., Mizugaki M. Human CYP4B1 gene in the japanese population analyzed by denaturing HPLC. Drug Metab. Pharmacokinet 2004; 19: 114–119, [INFOTRIEVE], [CSA], [CROSSREF]
- Hoch U., Ortiz De Montellano P. R. Covalently linked heme in cytochrome p4504a fatty acid hydroxylases. J. Biol. Chem 2001; 276: 11339–11346, [INFOTRIEVE], [CSA], [CROSSREF]
- Hoch U., Zhang Z., Kroetz D. L., Ortiz de Montellano P. R. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Arch. Biochem. Biophys 2000; 373: 63–71, [INFOTRIEVE], [CSA], [CROSSREF]
- Hsu H., Rainov N. G., Quinones A., Eling D. J., Sakamoto K. M., Spear M. A. Combined radiation and cytochrome CYP4B1/4-ipomeanol gene therapy using the EGR1 promoter. Anticancer Res 2003; 23: 2723–2728, [INFOTRIEVE], [CSA]
- Huijzer J. C., Adams J. D., Jr., Jaw J. Y., Yost G. S. Inhibition of 3-methylindole bioactivation by the cytochrome P-450 suicide substrates 1-aminobenzotriazole and alpha-methylbenzylaminobenzotriazole. Drug Metab. Dispos 1989; 17: 37–42, [INFOTRIEVE], [CSA]
- Imaoka S., Funae Y. Purification and characterization of rat pulmonary cytochrome P-450. J. Biochem. (Tokyo) 1990; 108: 33–36, [CSA]
- Imaoka S., Hayashi K., Hiroi T., Yabusaki Y., Kamataki T., Funae Y. A transgenic mouse expressing human CYP4B1 in the liver. Biochem. Biophys. Res. Commun 2001a; 284: 757–762, [INFOTRIEVE], [CSA], [CROSSREF]
- Imaoka S., Hiroi T., Tamura Y., Yamazaki H., Shimada T., Komori M., et al. Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: cloning and characterization of mouse CYP4B1. Arch. Biochem. Biophys 1995; 321: 255–262, [INFOTRIEVE], [CSA], [CROSSREF]
- Imaoka S., Yoneda Y., Matsuda T., Degawa M., Fukushima S., Funae Y. Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa. Biochem. Pharmacol 1997; 54: 677–683, [INFOTRIEVE], [CSA], [CROSSREF]
- Imaoka S., Yoneda Y., Sugimoto T., Hiroi T., Yamamoto K., Nakatani T., et al. CYP4B1 is a possible risk factor for bladder cancer in humans. Biochem. Biophys. Res. Commun 2000; 277: 776–780, [INFOTRIEVE], [CSA], [CROSSREF]
- Imaoka S., Yoneda Y., Sugimoto T., Ikemoto S., Hiroi T., Yamamoto K., Nakatani T., et al. Androgen regulation of CYP4B1 responsible for mutagenic activation of bladder carcinogens in the rat bladder: detection of CYP4B1 mRNA by competitive reverse transcription-polymerase chain reaction. Cancer Lett 2001b; 166: 119–123, [INFOTRIEVE], [CSA], [CROSSREF]
- Irving C. C., Wiseman R., Jr., Young J. M. Carcinogenicity of 2-acetylaminofluorene and N-hydroxy-2-acetylaminofluorene in the rabbit. Cancer Res 1967; 27: 838–848, [INFOTRIEVE], [CSA]
- Iscan M., Klaavuniemi T., Coban T., Kapucuoglu N., Pelkonen O., Raunio H. The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue. Breast Cancer Res. Treat 2001; 70: 47–54, [INFOTRIEVE], [CSA], [CROSSREF]
- Isern J., Meseguer A. Hormonal regulation and characterisation of the mouse Cyp4b1 gene 5′-flanking region. Biochem. Biophys. Res. Commun 2003; 307: 139–147, [INFOTRIEVE], [CSA], [CROSSREF]
- Janzowski C., Jacob D., Henn I., Zankl H., Pool-Zobel B. L., Wiessler M., et al. Mechanism of action of the urinary bladder carcinogen N-nitrosobutyl-3-carboxypropylamine. IARC Sci. Publ 1991; 332–338, [CSA]
- Kikuta Y., Kusunose E., Kusunose M. Prostaglandin and leukotriene omega-hydroxylases. Prostaglandins Other Lipid. Mediat 2002; 68–69: 345–362, [INFOTRIEVE], [CSA]
- Lai C. C., Miller E. C., Miller J. A., Liem A. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice. Carcinogenesis 1988; 9: 1295–1302, [INFOTRIEVE], [CSA]
- Laniado-Schwartzman M. Cytochrome P450 and arachidonic acid metabolism in the corneal epithelium: role in inflammation. Advances in Ocular Toxicology, K. Green, H. F. Edelhauser, R. B. Hackett, D. S. Hull, D. E. Potter, R. C. Tripathi. Plenum Press, New York 1997; 3–20
- Lasker J. M., Chen W. B., Wolf I., Bloswick B. P., Wilson P. D., Powell P. K. Formation of 20-hydroxyeicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp4F2 and Cyp4A11. J. Biol. Chem 2000; 275: 4118–4126, [INFOTRIEVE], [CSA], [CROSSREF]
- Lo-Guidice J. M., Allorge D., Cauffiez C., Chevalier D., Lafitte J. J., Lhermitte M., et al. Genetic polymorphism of the human cytochrome P450 CYP4B1: evidence for a non-functional allelic variant. Pharmacogenetics 2002; 12: 367–374, [INFOTRIEVE], [CSA], [CROSSREF]
- Mastyugin V., Aversa E., Bonazzi A., Vafaes C., Mieyal P., Schwartzman M. L. Hypoxia-induced production of 12-hydroxyeicosanoids in the corneal epithelium: involvement of a cytochrome P-4504B1 isoform. J. Pharmacol. Exp. Ther 1999; 289: 1611–1619, [INFOTRIEVE], [CSA]
- Mastyugin V., Mezentsev A., Zhang W. X., Ashkar S., Dunn M. W., Laniado-Schwartzman M. Promoter activity and regulation of the corneal CYP4B1 gene by hypoxia. J. Cell Biochem 2004; 91: 1218–1238, [INFOTRIEVE], [CSA], [CROSSREF]
- Mastyugin V., Mosaed S., Bonazzi A., Dunn M. W., Schwartzman M. L. Corneal epithelial VEGF and cytochrome P450 4B1 expression in a rabbit model of closed eye contact lens wear. Curr. Eye Res 2001; 23: 1–10, [INFOTRIEVE], [CSA], [CROSSREF]
- McKinnon R. A., Burgess W. M., Gonzalez F. J., Gasser R., McManus M. E. Species-specific expression of CYP4B1 in rabbit and human gastrointestinal tissues. Pharmacogenetics 1994; 4: 260–270, [INFOTRIEVE], [CSA]
- McKinnon R. A., McManus M. E. Localization of cytochromes P450 in human tissues: implications for chemical toxicity. Pathology 1996; 28: 148–155, [INFOTRIEVE], [CSA], [CROSSREF]
- Mezentsev A., Mastyugin V., Seta F., Ashkar S., Kemp R., Reddy D. S., et al. Transfection of cytochrome P4504B1 into the cornea increases angiogenic activity of the limbal vessels. J. Pharmacol. Exp. Ther 2005; 315: 42–50, [INFOTRIEVE], [CSA], [CROSSREF]
- Miller J. A. Recent studies on the metabolic activation of chemical carcinogens. Cancer Res 1994; 54: 1879s–1881s, [INFOTRIEVE], [CSA]
- Mohr L., Rainov N. G., Mohr U. G., Wands J. R. Rabbit cytochrome P450 4B1: a novel prodrug activating gene for pharmacogene therapy of hepatocellular carcinoma. Cancer Gene. Ther 2000; 7: 1008–1014, [INFOTRIEVE], [CSA], [CROSSREF]
- Muerhoff A. S., Williams D. E., Reich N. O., CaJacob C. A., Ortiz de Montellano P. R., Masters B. S. Prostaglandin and fatty acid omega- and (omega-1)-oxidation in rabbit lung. Acetylenic fatty acid mechanism-based inactivators as specific inhibitors. J. Biol. Chem 1989; 264: 749–756, [INFOTRIEVE], [CSA]
- Nelson D. R., Zeldin D. C., Hoffman S. M., Maltais L. J., Wain H. M., Nebert D. W. Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 2004; 14: 1–18, [INFOTRIEVE], [CSA], [CROSSREF]
- Nguyen X., Wang M. H., Reddy K. M., Falck J. R., Schwartzman M. L. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Am. J. Physiol 1999; 276: R1691–R1700, [INFOTRIEVE], [CSA]
- Nhamburo P. T., Gonzalez F. J., McBride O. W., Gelboin H. V., Kimura S. Identification of a new P450 expressed in human lung: complete cDNA sequence, cDNA-directed expression, and chromosome mapping. Biochemistry 1989; 28: 8060–8066, [INFOTRIEVE], [CSA], [CROSSREF]
- Parandoosh Z., Fujita V. S., Coon M. J., Philpot R. M. Cytochrome P-450 isozymes 2 and 5 in rabbit lung and liver. Comparisons of structure and inducibility. Drug Metab. Dispos 1987; 15: 59–67, [INFOTRIEVE], [CSA]
- Poch M. T., Cutler N. S., Yost G. S., Hines R. N. Molecular mechanisms regulating human CYP4B1 lung-selective expression. Drug Metab. Dispos 2005; 33: 1174–1184, [INFOTRIEVE], [CSA], [CROSSREF]
- Rae T. D., Goff H. M. The heme prosthetic group of lactoperoxidase. Structural characteristics of heme l and heme l-peptides. J. Biol. Chem 1998; 273: 27968–27977, [INFOTRIEVE], [CSA], [CROSSREF]
- Rainov N. G., Dobberstein K. U., Sena-Esteves M., Herrlinger U., Kramm C. M., Philpot R. M., et al. New prodrug activation gene therapy for cancer using cytochrome P450 4B1 and 2-aminoanthracene/4-ipomeanol. Hum. Gene. Ther 1998a; 9: 1261–1273, [INFOTRIEVE], [CSA]
- Rainov N. G., Sena-Esteves M., Fraefel C., Dobberstein K. U., Chiocca E. A., Breakefield X. O. A chimeric fusion protein of cytochrome CYP4B1 and green fluorescent protein for detection of pro-drug activating gene delivery and for gene therapy in malignant glioma. Adv. Exp. Med. Biol 1998b; 451: 393–403, [INFOTRIEVE], [CSA]
- Ramakanth S., Thornton-Manning J. R., Wang H., Maxwell H., Yost G. S. Correlation between pulmonary cytochrome P450 transcripts and the organ-selective pneumotoxicity of 3-methylindole. Toxicol. Lett 1994; 71: 77–85, [INFOTRIEVE], [CSA], [CROSSREF]
- Rettie A. E., Boberg M., Rettenmeier A. W., Baillie T. A. Cytochrome P-450-catalyzed desaturation of valproic acid in vitro. Species differences, induction effects, and mechanistic studies. J. Biol. Chem 1988; 263: 13733–13738, [INFOTRIEVE], [CSA]
- Rettie A. E., Sheffels P. R., Korzekwa K. R., Gonzalez F. J., Philpot R. M., Baillie T. A. CYP4 isozyme specificity and the relationship between omega-hydroxylation and terminal desaturation of valproic acid. Biochemistry 1995; 34: 7889–7895, [INFOTRIEVE], [CSA], [CROSSREF]
- Robertson I. G., Serabjit-Singh C., Croft J. E., Philpot R. M. The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital. Mol. Pharmacol 1983; 24: 156–162, [INFOTRIEVE], [CSA]
- Robertson L. G., Philpot R. M., Zeiger E., Wolf C. R. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1. Mol. Pharmacol 1981; 20: 662–668, [INFOTRIEVE], [CSA]
- Rowinsky E. K., Noe D. A., Ettinger D. S., Christian M. C., Lubejko B. G., Fishman E. K., et al. Phase I and pharmacological study of the pulmonary cytotoxin 4-ipomeanol on a single dose schedule in lung cancer patients: hepatotoxicity is dose limiting in humans. Cancer Res 1993; 53: 1794–1801, [INFOTRIEVE], [CSA]
- Schulze J., Richter E., Philpot R. M. Tissue, species, and substrate concentration differences in the position-selective hydroxylation of N-nitrosodibutylamine. Relationship to the distribution of cytochrome P-450 isozymes 2 (IIB) and 5 (IVB). Drug Metab. Dispos 1990; 18: 398–402, [INFOTRIEVE], [CSA]
- Scott E. E., White M. A., He Y. A., Johnson E. F., Stout C. D., Halpert J. R. Structure of mammalian cytochrome P450 2B4 complexed with 4-(4-chlorophenyl)imidazole at 1.9-Å resolution: insight into the range of P450 conformations and the coordination of redox partner binding. J. Biol. Chem 2004; 279: 27294–27301, [INFOTRIEVE], [CSA], [CROSSREF]
- Serabjit-Singh C. J., Albro P. W., Robertson I. G., Philpot R. M. Interactions between xenobiotics that increase or decrease the levels of cytochrome P-450 isozymes in rabbit lung and liver. J. Biol. Chem 1983; 258: 12827–12834, [INFOTRIEVE], [CSA]
- Serabjit-Singh C. J., Wolf C. R., Philpot R. M. The rabbit pulmonary monooxygenase system. Immunochemical and biochemical characterization of enzyme components. J. Biol. Chem 1979; 254: 9901–9907, [INFOTRIEVE], [CSA]
- Sharma R. K., Doig M. V., Lewis D. F., Gibson G. G. Role of hepatic and renal cytochrome P-450 IVA1 in the metabolism of lipid substrates. Biochem. Pharmacol 1989; 38: 3621–3629, [INFOTRIEVE], [CSA], [CROSSREF]
- Simpson A. E. The cytochrome P450 4 (CYP4) family. Gen. Pharmacol 1997; 28: 351–359, [INFOTRIEVE], [CSA]
- Skiles G. L., Yost G. S. Mechanistic studies on the cytochrome P450-catalyzed dehydrogenation of 3-methylindole. Chem. Res. Toxicol 1996; 9: 291–297, [INFOTRIEVE], [CSA], [CROSSREF]
- Slaughter S. R., Statham C. N., Philpot R. M., Boyd M. R. Covalent binding of metabolites of 4-ipomeanol to rabbit pulmonary and hepatic microsomal proteins and to the enzymes of the pulmonary cytochrome P-450-dependent monooxygenase system. J. Pharmacol. Exp. Ther 1983; 224: 252–257, [INFOTRIEVE], [CSA]
- Slaughter S. R., Wolf C. R., Marciniszyn J. P., Philpot R. M. The rabbit pulmonary monooxygenase system. partial structural characterization of the cytochrome P-450 components and comparison to the hepatic cytochrome P-450. J. Biol. Chem 1981; 256: 2499–2503, [INFOTRIEVE], [CSA]
- Smith B. R., Plummer J. L., Wolf C. R., Philpot R. M., Bend J. R. p-Xylene metabolism by rabbit lung and liver and its relationship to the selective destruction of pulmonary cytochrome P-450. J. Pharmacol. Exp. Ther 1982; 223: 736–742, [INFOTRIEVE], [CSA]
- Smith P. B., Tiano H. F., Nesnow S., Boyd M. R., Philpot R. M., Langenbach R. 4‐Ipomeanol and 2-aminoanthracene cytotoxicity in C3H/10T1/2 cells expressing rabbit cytochrome P450 4B1. Biochem. Pharmacol 1995; 50: 1567–1575, [INFOTRIEVE], [CSA], [CROSSREF]
- Steffens S., Frank S., Fischer U., Heuser C., Meyer K. L., Dobberstein K. U., et al. Enhanced green fluorescent protein fusion proteins of herpes simplex virus type 1 thymidine kinase and cytochrome P450 4B1: applications for prodrug-activating gene therapy. Cancer Gene. Ther 2000; 7: 806–812, [INFOTRIEVE], [CSA], [CROSSREF]
- Tang W., Abbott F. S. Bioactivation of a toxic metabolite of valproic acid, (E)-2-propyl-2,4-pentadienoic acid, via glucuronidation. LC/MS/MS characterization of the GSH-glucuronide diconjugates. Chem. Res. Toxicol 1996; 9: 517–526, [INFOTRIEVE], [CSA], [CROSSREF]
- Thornton-Manning J., Appleton M. L., Gonzalez F. J., Yost G. S. Metabolism of 3-methylindole by vaccinia-expressed P450 enzymes: correlation of 3-methyleneindolenine formation and protein-binding. J. Pharmacol. Exp. Ther 1996; 276: 21–29, [INFOTRIEVE], [CSA]
- Vafeas C., Mieyal P. A., Urbano F., Falck J. R., Chauhan K., Berman M., et al. Hypoxia stimulates the synthesis of cytochrome P450-derived inflammatory eicosanoids in rabbit corneal epithelium. J. Pharmacol. Exp. Ther 1998; 287: 903–910, [INFOTRIEVE], [CSA]
- Vanderslice R. R., Boyd J. A., Eling T. E., Philpot R. M. The cytochrome P-450 monooxygenase system of rabbit bladder mucosa: enzyme components and isozyme 5-dependent metabolism of 2-aminofluorene. Cancer Res 1985; 45: 5851–5858, [INFOTRIEVE], [CSA]
- Vanderslice R. R., Domin B. A., Carver G. T., Philpot R. M. Species-dependent expression and induction of homologues of rabbit cytochrome P-450 isozyme 5 in liver and lung. Mol. Pharmacol 1987; 31: 320–325, [INFOTRIEVE], [CSA]
- Verschoyle R. D., Philpot R. M., Wolf C. R., Dinsdale D. CYP4B1 activates 4-ipomeanol in rat lung. Toxicol. Appl. Pharmacol 1993; 123: 193–198, [INFOTRIEVE], [CSA], [CROSSREF]
- Wang M. H., Stec D. E., Balazy M., Mastyugin V., Yang C. S., Roman R. J., et al. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein. Arch. Biochem. Biophys 1996; 336: 240–250, [INFOTRIEVE], [CSA], [CROSSREF]
- Waxman D. J. P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR. Arch. Biochem. Biophys 1999; 369: 11–23, [INFOTRIEVE], [CSA], [CROSSREF]
- Waxman D. J., Lapenson D. P., Aoyama T., Gelboin H. V., Gonzalez F. J., Korzekwa K. Steroid hormone hydroxylase specificities of eleven cDNA-expressed human cytochrome P450s. Arch. Biochem. Biophys 1991; 290: 160–166, [INFOTRIEVE], [CSA], [CROSSREF]
- Wester M. R., Yano J. K., Schoch G. A., Yang C., Griffin K. J., Stout C. D., et al. The structure of human cytochrome P450 2C9 complexed with flurbiprofen at 2.0-Å resolution. J. Biol. Chem 2004; 279: 35630–35637, [INFOTRIEVE], [CSA], [CROSSREF]
- Williams D. E., Hale S. E., Okita R. T., Masters B. S. A prostaglandin omega-hydroxylase cytochrome P-450 (P-450PG-omega) purified from lungs of pregnant rabbits. J. Biol. Chem 1984; 259: 14600–14608, [INFOTRIEVE], [CSA]
- Williams P. A., Cosme J., Vinkovic D. M., Ward A., Angove H. C., Day P. J., et al. Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone. Science 2004; 305: 683–686, [INFOTRIEVE], [CSA], [CROSSREF]
- Williams P. A., Cosme J., Ward A., Angove H. C., Matak Vinkovic D., Jhoti H. Crystal structure of human cytochrome P450 2C9 with bound warfarin. Nature 2003; 424: 464–468, [INFOTRIEVE], [CSA]
- Windmill K. F., McKinnon R. A., Zhu X., Gaedigk A., Grant D. M., McManus M. E. The role of xenobiotic metabolizing enzymes in arylamine toxicity and carcinogenesis: functional and localization studies. Mutat. Res 1997; 376: 153–160, [INFOTRIEVE], [CSA]
- Wolf C. R., Szutowski M. M., Ball L. M., Philpot R. M. The rabbit pulmonary monooxygenase system: characteristics and activities of two forms of pulmonary cytochrome P-450. Chem. Biol. Interact 1978; 21: 29–43, [INFOTRIEVE], [CSA], [CROSSREF]
- Xu F., Falck J. R., Ortiz de Montellano P. R., Kroetz D. L. Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes. J. Pharmacol. Exp. Ther 2004; 308: 887–895, [INFOTRIEVE], [CSA], [CROSSREF]
- Yano J. K., Hsu M. H., Griffin K. J., Stout C. D., Johnson E. F. Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen. Nat. Struct. Mol. Biol 2005; 12: 822–823, [INFOTRIEVE], [CSA], [CROSSREF]
- Yano J. K., Wester M. R., Schoch G. A., Griffin K. J., Stout C. D., Johnson E. F. The structure of human microsomal cytochrome P450 3A4 determined by X-ray crystallography to 2.05-A resolution. J. Biol. Chem 2004; 279: 38091–38094, [INFOTRIEVE], [CSA], [CROSSREF]
- Yokotani N., Sogawa K., Matsubara S., Gotoh O., Kusunose E., Kusunose M., et al. cDNA cloning of cytochrome P-450 related to P-450p-2 from the cDNA library of human placenta. Gene structure and expression. Eur. J. Biochem 1990; 187: 23–29, [INFOTRIEVE], [CSA], [CROSSREF]
- Yost G. S. Mechanisms of 3-methylindole pneumotoxicity. Chem. Res. Toxicol 1989; 2: 273–279, [INFOTRIEVE], [CSA], [CROSSREF]
- Zeldin D. C., Plitman J. D., Kobayashi J., Miller R. F., Snapper J. R., Falck J. R., et al. The rabbit pulmonary cytochrome P450 arachidonic acid metabolic pathway: characterization and significance. J. Clin. Invest 1995; 95: 2150–2160, [INFOTRIEVE], [CSA]
- Zheng Y. M., Fisher M. B., Yokotani N., Fujii-Kuriyama Y., Rettie A. E. Identification of a meander region proline residue critical for heme binding to cytochrome P450: implications for the catalytic function of human CYP4B1. Biochemistry 1998; 37: 12847–12851, [INFOTRIEVE], [CSA], [CROSSREF]
- Zheng Y. M., Baer B. R., Kneller M. B., Henne K. R., Kunze K. L., Rettie A. E. Covalent heme binding to CYP4B1 via Glu310 and a carbocation porphyrin intermediate. Biochemistry 2003; 42: 4601–4606, [INFOTRIEVE], [CSA], [CROSSREF]
- Zheng Y. M., Henne K. R., Charmley P., Kim R. B., McCarver D. G., Cabacungan E. T., et al. Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis. Toxicol. Appl. Pharmacol 2003; 186: 119–126, [INFOTRIEVE], [CSA], [CROSSREF]
- Zimmerman H. J., Ishak K. G. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 1982; 2: 591–597, [INFOTRIEVE], [CSA]